Clinical Trial for Oral Formula of Vanillin and Wheat Germ Oil for Treatment of Mild and Moderate COVID-19 Viral Disease
Mild-to-moderate COVID-19
Enrolment: 120 · Results not recorded
Nutraceutical
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Mild-to-moderate COVID-19
Enrolment: 120 · Results not recorded
2 studies reported at therapy level; 2 evidence entries itemised.
Model: Carbon tetrachloride (CCl4)-induced acute liver injury
Vanillin reduced liver enzymes, oxidative stress and inflammatory cytokines and protected against CCl4-induced liver injury.
Extraction: extract · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.
Model: Acute oxidative brain injury induced by a single intraperitoneal injection of carbon tetrachloride (1 mL/kg)
Vanillin significantly protected the brain, decreasing lipid peroxidation and nitrite levels and elevating antioxidative enzyme activities and glutathione, blocking carbon tetrachloride induced oxidative brain damage.
Extraction: extract · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.